s&o logo
  • News
  • Trade Ideas
  • Education
  • Community
Sign Up!
News, Trade Ideas

Nebius Group Secures $700 Million in AI Infrastructure Funding Led by Nvidia

December 2, 2024 Elisa Clay No comments yet

Nebius Group (NBIS), a fast-growing AI infrastructure firm, announced on Monday that it had raised $700 million in a private placement from investors, including Nvidia (NVDA), Accel, and Orbis Investments. The funding positions Nebius as a significant player in the race to build the technological backbone for artificial intelligence applications.

The announcement comes as Nebius strengthens its identity as an independent entity, following its split from Russian tech giant Yandex earlier this year. The $5.4 billion restructuring deal in July separated Yandex’s domestic and international operations, paving the way for Nebius’s emergence and its Nasdaq listing revival.

Building the AI Backbone

Founded by Arkady Volozh, the former CEO of Yandex, Nebius aims to capitalize on the surging demand for AI infrastructure. The company is focusing on developing advanced clusters of graphics processing units (GPUs), cloud platforms, and other essential tools for AI developers.

Volozh stated that the $700 million injection would enable Nebius to scale its projects at an accelerated pace, enhancing its ability to meet the needs of a rapidly evolving AI landscape. “This financing gives us additional firepower to build infrastructure faster and on a larger scale,” Volozh said during a media briefing.

Nebius has already committed $1 billion in investments by mid-2025, though Volozh suggested that this figure might increase as the company expands its operations and client base.

U.S. Expansion and Revenue Growth

The United States represents a critical growth area for Nebius, with over half of its clientele based in the country. The company is leasing data center space in Kansas City, Missouri, and has hinted at further expansion in the region. This strategic focus on the U.S. market underscores Nebius’s ambition to compete with established AI infrastructure providers.

Nebius also reported a significant boost in its financial outlook, increasing its annualized run-rate revenue target for 2025 to between $750 million and $1 billion. This marks an improvement from the previous estimate of $500 million at the lower end.

Details of the Funding Round

In the private placement, Nebius issued 33,333,334 Class A shares at $21 per share, a 3% premium to the volume-weighted average price of its shares since trading resumed on Nasdaq. The company described the financing round as oversubscribed, reflecting robust investor interest.

This strong demand also led Nebius to scrap a previously approved share buyback plan. “Based on the strong level of investor engagement and technical dynamics observed since our Nasdaq trading resumed, we believe shareholders who wanted to exit have had the opportunity to do so at favorable prices,” said Nebius Board Chairman John Boynton.

The Road Ahead

Nebius’s rise coincides with a broader push among technology firms to build the infrastructure that underpins AI. With Nvidia’s backing—widely regarded as a leader in GPU technology—Nebius is positioned to leverage cutting-edge hardware and software solutions to support AI applications across industries.

The company’s origins tie it to Yandex, which faced significant challenges following Russia’s invasion of Ukraine. Trading of Yandex shares on Nasdaq was suspended, and Nebius emerged as part of the restructuring. While distancing itself from its Russian roots, Nebius has successfully carved out a new identity focused on innovation and global expansion.

As the AI race intensifies, Nebius’s ability to attract significant investments and scale its operations rapidly underscores its potential to become a formidable player in the industry. With ambitious revenue targets, a growing U.S. presence, and plans for increased investment, the company is poised to play a critical role in shaping the future of AI infrastructure.

For investors and AI developers alike, Nebius represents a compelling story of resilience, reinvention, and innovation.

You might like this article: Trump’s Tariffs Could Drive Up Car Prices and Slash Automaker Profits

  • AI
  • Capital Raising
  • Nvidia
  • Stock Market
  • Stocks

Post navigation

Previous
Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Education (15)
  • Featured (46)
  • News (85)
  • Trade Ideas (39)

Recent posts

  • FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
  • Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
  • flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

Tags

BDRX CDT Conduit Conference Call CURR CURRENC Earnings Evergreen GH Research GHRS Grail GRAL HOLO IINN Inspira Technologies Interview IPWR JTAI KULR LCID Litigation LLY Lucid Motors M&A MedTech MicroCloud Movers MSTR My Size MYSZ News NLSP Novo Nordisk NVO Options Partnerships QNTM Quantum BioPharma Stock Market Stocks TAOP TELO Telomir Pharmaceuticals Traws Pharma TRWS

Continue reading

Featured, News, Trade Ideas

FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity

March 3, 2025 Elisa Clay No comments yet

BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single site involved in the TRANQUILITY II Phase 3 trial under 21 C.F.R.20.64(d)(3). The FDA’s designation of “Voluntary Action Indicated” (VAI) signals that while minor issues may have been identified, no regulatory action is required, further […]

Featured, News, Trade Ideas

Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine

February 20, 2025 Elisa Clay No comments yet

Telomir Pharmaceuticals (NASDAQ: TELO) has achieved a major scientific breakthrough by stabilizing Silver(II) (Ag²⁺) using its proprietary compound, Telomir-1. This advancement overcomes a key challenge in silver-based medicine, unlocking new possibilities for antimicrobial treatments, wound care, and infection-resistant medical coatings. Silver(II) offers superior antibacterial action, faster wound healing, and immune-modulating properties compared to traditional Silver(I) […]

Featured, News, Trade Ideas

flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

February 14, 2025 Elisa Clay No comments yet

flyExclusive (NYSE American: FLYX), a leading provider of premium jet charter experiences, has entered into a definitive agreement to acquire the aviation business of Jet.AI (NASDAQ: JTAI). The deal will allow flyExclusive to expand its fleet and market presence while enabling Jet.AI to transition into a pure-play AI solutions company. Under the terms of the […]

s&o logo

Our primary goal is to empower retail investors with helpful news, guides and trading ideas.

Helpful Links
  • News
  • Trade Ideas
  • Education
  • Community
Resources
  • Privacy Policy
  • Terms & Conditions
  • Contact
Get in touch
  • Email us!

© Copyright 2024, stocks&options. All Rights Reserved.